| 1068 |
1025: Increased, Hyperplasia (follicular cells) |
1026: Increased Apoptosis, Adenomas/carcinomas (follicular cell) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2426 |
1025: Increased, Hyperplasia (follicular cells) |
741: Increase, Adenomas/carcinomas (follicular cell) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 1107 |
1069: Increased, Hyperplasia (glandular epithelial cells of endometrium) |
1070: Increased, adenosquamous carcinomas of endometrium |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1123 |
1085: Increased, hyperplasia (mammary gland) |
1080: Increased, latency period |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1124 |
1085: Increased, hyperplasia (mammary gland) |
1079: Increased, Adenomas/carcinomas (mammary) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1067 |
1024: Increased, Hypertrophy and proliferation (follicular cell) |
1025: Increased, Hyperplasia (follicular cells) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2427 |
1024: Increased, Hypertrophy and proliferation (follicular cell) |
740: Increase, Hyperplasia (follicular cells) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 342 |
376: Increased, Induced Mutations in Critical Genes |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 346 |
376: Increased, Induced Mutations in Critical Genes |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 351 |
376: Increased, Induced Mutations in Critical Genes |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 549 |
376: Increased, Induced Mutations in Critical Genes |
491: Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF) |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 891 |
376: Increased, Induced Mutations in Critical Genes |
872: Increase, Site of Contact Nasal Tumors |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 762 |
726: Increased, Induction of pyruvate dehydrogenase (PDH) |
769: Increase, Oxidative metabolism |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1063 |
1020: Increased, induction of UDPGT's in liver |
1021: Increased, T4/T3 catabolism |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1127 |
1087: Increased, inflammation |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1048 |
1012: Increased, Inhibitory postsynaptic potential |
1013: Inhibition, Motor neuron activity |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1054 |
1012: Increased, Inhibitory postsynaptic potential |
1014: Induction, Somatic muscle paralysis |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1058 |
1012: Increased, Inhibitory postsynaptic potential |
1019: Induction, pharyngeal muscle paralysis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 547 |
493: Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts |
376: Increased, Induced Mutations in Critical Genes |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 362 |
389: Increased, Intracellular Calcium overload |
177: Mitochondrial dysfunction |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 892 |
389: Increased, Intracellular Calcium overload |
618: Decreased, Neuronal network function in adult brain |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1860 |
389: Increased, Intracellular Calcium overload |
613: Occurrence, Epileptic seizure |
Feb 13, 2019 |
Feb 13, 2019 |
None
|
| 1862 |
389: Increased, Intracellular Calcium overload |
55: Cell injury/death |
Feb 19, 2019 |
Sep 3, 2023 |
1 AOP
|
| 2140 |
389: Increased, Intracellular Calcium overload |
1788: Status epilepticus |
May 21, 2020 |
May 21, 2020 |
None
|
| 2704 |
389: Increased, Intracellular Calcium overload |
2038: Activation, calpain |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|